TherapeuticsMD, Inc. (NYSE MKT:TXMD) Q3 2018 Earnings Conference Call Transcript

Nov 07, 2018 • 04:30 pm ET

Previous

TherapeuticsMD, Inc. (NYSE MKT:TXMD) Q3 2018 Earnings Conference Call Transcript

Share
Close

Loading Event

Loading Transcript

Presentation
Operator
Operator

Good afternoon, ladies and gentlemen, and thank you for joining us for the TherapeuticsMD's Third Quarter 2018 Financial Results Conference Call. Following prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to TherapeuticsMD's VP of IR, Nichol Ochsner. Nichol?

Executive
Nichol Ochsner

Good afternoon everyone. Thank you for joining today to discuss the third quarter 2018 financial results and business update. This afternoon, TherapeuticsMD issued a press release announcing our third quarter financial results. The press release is available on the company's website, therapeuticsmd.com, in the Investors & Media section. On today's call are CEO, Robert Finizio; CFO, Daniel Cartwright; Co-Founder and Director, Dr. Brian Bernick; Chief Commercial Officer, Dawn Halkuff; and Chief Medical Officer, Dr. Sebastian Mirkin. (Forward-Looking Cautionary Statements) An audio recording and webcast replay for today's conference call will also be available online in the Investors & Media section of the company's website. For the benefit of those who may be listening to the replay or archived webcast, this call was held and recorded November 7, 2018. With that, I'll turn the call over to TherapeuticsMD's CEO, Rob Finizio.